PDB60 COST-EFFECTIVENESS OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U300 IN THE NETHERLANDS: EVIDENCE FROM A RANDOMISED CONTROLLED TRIAL (RCT)

Autor: Evans, M., Moes, R.J., Pedersen, K.S., Gundgaard, J.
Zdroj: In Value in Health November 2019 22 Supplement 3:S583-S583
Databáze: ScienceDirect